Bryan Wahl serves as Executive at Tarsus Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Bryan Wahl has executed 15 insider transactions totaling $357.6K, demonstrating a bearish approach to their equity position. Their most recent transaction on Mar 18, 2024 involved selling 4,436 shares valued at $135.7K.
Bryan Wahl currently holds 40,951 shares of Tarsus Pharmaceuticals, Inc. (TARS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Bryan Wahl has been a net seller of TARS stock. They have purchased $0 and sold $357.6K worth of shares.
Bryan Wahl's most recent insider trade was on Mar 18, 2024, when they sold 4,436 shares at $30.60 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Nov 30, 2023 | TARS | $136.3K | Sale | 8,356 | $16.31 | Discretionary |
| Nov 29, 2023 | TARS | $0 | Option Exercise | 23,920 | $N/A | Discretionary |
| Mar 23, 2023 | TARS | $4.5K | Sale | 371 | $12.15 | Discretionary |
| Mar 22, 2023 | TARS | $4.5K | Sale | 357 | $12.64 | Discretionary |
| Mar 21, 2023 | TARS | $4.5K | Sale | 350 | $12.89 | Discretionary |
| Mar 20, 2023 | TARS | $4.5K | Sale | 357 | $12.61 | Discretionary |
| Mar 17, 2023 | TARS | $4.5K | Sale | 339 | $13.28 | Discretionary |
| Mar 16, 2023 | TARS | $4.5K | Sale | 337 | $13.43 | Discretionary |
| Mar 15, 2023 | TARS | $0 | Option Exercise | 4,790 | $N/A | Discretionary |
| Dec 2, 2022 | TARS | $19.5K | Sale | 1,154 | $16.90 | Discretionary |
| Dec 1, 2022 | TARS | $19.5K | Sale | 1,164 | $16.75 | Discretionary |
| Nov 30, 2022 | TARS | $19.5K | Sale | 1,183 | $16.50 | Discretionary |
| Nov 29, 2022 | TARS | $0 | Option Exercise | 10,251 | $N/A | Discretionary |